1. Home
  2. RLMD vs SKYQ Comparison

RLMD vs SKYQ Comparison

Compare RLMD & SKYQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • SKYQ
  • Stock Information
  • Founded
  • RLMD 2004
  • SKYQ 2019
  • Country
  • RLMD United States
  • SKYQ United States
  • Employees
  • RLMD N/A
  • SKYQ N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • SKYQ
  • Sector
  • RLMD Health Care
  • SKYQ
  • Exchange
  • RLMD Nasdaq
  • SKYQ NYSE
  • Market Cap
  • RLMD 11.5M
  • SKYQ 13.5M
  • IPO Year
  • RLMD N/A
  • SKYQ N/A
  • Fundamental
  • Price
  • RLMD $0.30
  • SKYQ $0.63
  • Analyst Decision
  • RLMD Hold
  • SKYQ
  • Analyst Count
  • RLMD 4
  • SKYQ 0
  • Target Price
  • RLMD $4.25
  • SKYQ N/A
  • AVG Volume (30 Days)
  • RLMD 382.7K
  • SKYQ 44.8K
  • Earning Date
  • RLMD 03-27-2025
  • SKYQ 05-14-2025
  • Dividend Yield
  • RLMD N/A
  • SKYQ N/A
  • EPS Growth
  • RLMD N/A
  • SKYQ N/A
  • EPS
  • RLMD N/A
  • SKYQ N/A
  • Revenue
  • RLMD N/A
  • SKYQ $23,364,188.00
  • Revenue This Year
  • RLMD N/A
  • SKYQ N/A
  • Revenue Next Year
  • RLMD N/A
  • SKYQ N/A
  • P/E Ratio
  • RLMD N/A
  • SKYQ N/A
  • Revenue Growth
  • RLMD N/A
  • SKYQ N/A
  • 52 Week Low
  • RLMD $0.24
  • SKYQ $0.56
  • 52 Week High
  • RLMD $5.09
  • SKYQ $5.49
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 50.05
  • SKYQ N/A
  • Support Level
  • RLMD $0.26
  • SKYQ N/A
  • Resistance Level
  • RLMD $0.32
  • SKYQ N/A
  • Average True Range (ATR)
  • RLMD 0.02
  • SKYQ 0.00
  • MACD
  • RLMD 0.00
  • SKYQ 0.00
  • Stochastic Oscillator
  • RLMD 67.34
  • SKYQ 0.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About SKYQ SKY QUARRY INC

Sky Quarry Inc is a development-stage oil-producing and refining company. The company along with its subsidiaries is engaged in deploying technologies to facilitate the recycling of waste asphalt shingles and remediation of oil-saturated soils. The recycling and production of oil from asphalt shingles is expected to reduce the dependence on landfills for the disposal of waste and to also reduce dependence on foreign and domestic virgin crude oil extraction for industrial uses.

Share on Social Networks: